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Y1159.0) vs 232.29 (52.0 to 1307.0) Hounsﬁeld Units; P¼.033). Median local plaque
volume was higher in lesions with complex PCI compared to those with non-complex
interventions with a mean of 475.07 (92.0 to 1229.0) mm3 Vs 270.24 (69.0 to
824.0) mm3. The plaque area was found statistically signiﬁcantly higher in complex
PCI procedures over the non complex ones with the mean plaque area in the complex
procedures was19.40  14.61 mm2 and in the non complex ones, it was 11.24 
7.94 mm2 with the P value ¼ 0.011. Complex PCI had a higher rate of calciﬁed plaques
(27.9% vs. 5.9%; P¼.046).
CONCLUSION pre-procedural CCTA parameters indicate complexity of PCI. Thus, we
suggest that in patients with suspected complex coronary anatomy, prior CCTA adds
important complementary information to coronary angiography for planning subse-
quent PCI strategy.
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INTRODUCTION Several techniques have been used to deliver stents in the presence
of complex coronary anatomies. Some examples are the buddy wire technique, high
support guidewires and deep intubation of the guiding catheter. If these techniques
are not successful there are few other resources that the inteventionalist can use to
adequately treat these complex lesions. One of these alternatives is the use of coro-
nary extension systems like the mother-child catheter technique (5 in 6 catheters).
There are few studies that evaluate in the real world practice the usefulness of these
devices.
METHODS During the time period since January 2012 to October 2014 we enrolled 63
consecutive patients in which we used coronary extension systems (Guideliner or
Heart-trail II catheters) to aid in coronary intervention. We recorded the angiographic
technical variables related to the use and performance of these coronary extension
systems.
RESULTS Seventy two lesions in 63 patients were treated using mother-child cathe-
ters. The average age was 65.2+9.7 years. Diabetes was present in 55 (87%) patients.
Most of the patients had chronic stable coronary artery disease (57% of the patients).
Sixty three Guideliner catheters and 9 Heart-trail II catheters were used. The type C
lesion was treated principally. The reason to use the coronary extension systems was:
lack of support of the guiding catheter in 59% of the cases and inability to deliver the
stent in 84.7% of the cases. Child-Catheter intubation distance into the native coro-
nary artery was 30.5+21.2 mm. The success rate to advance the extension system to
deliver the stent into the coronary artery was 90.2%. The most frequent complication
seen was coronary artery C type dissection (6.9% of the cases). No deaths related to
the use of the extension systems were observed.
CONCLUSIONS Coronary extension systems improve the back-up support necessary
to deliver stents in the presence of complex coronary anatomies with a low rate of
serious complications.FFR
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BACKGROUND There is still a controversy in the treatment of long coronary lesions.
Therefore, systemic data on the factors inﬂuencing PCI outcomes in the setting of
diffuse coronary artery disease is needed. The aim of our study was to evaluate the
inﬂuence of post procedural FFR on long term outcomes after FFR guided PCI on long
coronary lesions.
METHODS A total of 74 consecutive patients with signiﬁcant (FFR<0.8) coronary
artery lesions 30 mm in length were included to the prospective study. All patients
underwent FFR guided PCI with new generation Biolimus, Everolimus or Zotar-
olimus eluting stents. 100% angiographic procedure success was achieved. Based on
post procedural FFR patients were divided into two groups: FFR0.9 (n¼26) and
FFR<0.9 (n¼48). The primary outcome was target vessel revascularization (TVR) at
one year. Secondary outcomes included late lumen loss (LLL) and major adverse
cardiac events (MACE) at one year. In addition, the regression analysis between post
procedural FFR and outcomes at follow-up was performed. The angiographic and
FFR follow-up was scheduled at 9 months, clinical follow-up at 12 months after the
procedure.
RESULTS The average post procedural FFR in the groups of FFR0.9 and FFR<0.9
was 0.940.04 and 0.850.05 respectively. The baseline clinical characteristics
were similar between the two groups including mean age 66.818.61 and
65.719.95 years (p¼0,580), male gender 65.4% and 76.6% (p¼0.304), diabetes
19.2% and 23.4% (p¼0.680). However, the length of stents needed to cover the
lesion was signiﬁcantly longer (55.1715.2 vs. 42.158.39 mm, p<0,001) and there
were more bifurcation lesions [24 (51.1%) vs. 5 (19.2%), p¼0,008] in FFR<0.9
group. At follow-up, TVR rate was 4.2% vs. 10.9% (p¼0.342), MACE rate 20.8%
vs. 21.3% (p¼0.965), LLL 0.190.43 vs. 0.270.41 (p¼0.540) in the groups of
FFR0.9 and FFR<0.9 respectively. On regression analysis there was no statisti-
cally signiﬁcant correlation between post procedural FFR and clinical outcomes at
follow-up.
CONCLUSION Longer stent length and bifurcation lesions are associated with lower
post procedural FFR values, but FFR after PCI on long coronary lesions has no pre-
dictive value on long term clinical outcomes.
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OBJECTIVE Anatomical and functional mismatches are not uncommon in the
assessment of coronary lesions. The aim of this study was to identify clinical and
lesion speciﬁc factors affecting angiographic, anatomical and functional mismatch in
intermediate coronary lesions
METHOD In patients who underwent coronary angiography for clinical reason, frac-
tional ﬂow reserve (FFR) and quantitative coronary angiography (QCA) analyses for
intermediate stenotic lesions were performed simultaneously. Mismatches between
measured values were analyzed.
RESULT Ninety ﬁve intermediate lesions were assessed simultaneously by visual
angiography, FFR and QCA. Visual-FFR mismatch was found in 40% of the lesions
while reverse Visual-FFR mismatch was determined in nearly 14% of the lesions.
Mismatch and reverse mismatch between FFR and QCA parameters were observed in
10 % and 23% of the lesions. FFR value was signiﬁcant in 32% of lesions while visually
signiﬁcant stenosis was shown in 61% of lesions. Among the Visual-FFR reverse
mismatch group, the prevalence of culprit lesions within the LAD was signiﬁcantly
higher than other vessels (p value<0.02).
CONCLUSION There were high frequencies of angiographic, QCA and functional
mismatches in analyses of intermediate coronary lesions. LAD lesions showed the
highest mismatch. Angiographic or QCA estimation of lesion severity has consistently
resulted in inappropriate stenting of functionally non-signiﬁcant lesions or under
treatment of signiﬁcant lesions based on FFR.
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BACKGROUND With improved percutaneous coronary intervention (PCI) techniques,
PCI has emerged to be a safe option for revascularization with good long term out-
comes in selected patients with unprotected left main coronary artery (uLMCA) le-
sions. Overexpansion beyond nominal size is a common procedure to ensure
adequate stent apposition during left main stenting to improve clinical outcome.
However there is limited data concerning the feasibility and safety of aggressive post
dilation of metallic stent platforms during left main stenting to achieve apposition
and reduce focal underexpansion.
OBJECTIVES The objectives of this study are to investigate if overexpansion can be
achieved beyond the recommended stent expansion limit for a 4.0mm metallic stent
and to compare different expansion techniques to achieve optimal apposition and
study the effect of overexpansion on the mechanical performance of the stent.
METHODS We performed bench testing to measure the effect of overexpansion on the
stent performance of thin strut (74mm) 4.0 mm drug eluting platinum chromium
stents (DES) (Synergy IITM, Boston Scientiﬁc, Natwick, MA, USA) in silicon phantom
models of 6 mm diameter. We tested the stents in the following 5 models; using a
6.0 mm balloon with Proximal Optimisation Technique (POT) at low (nominal)
pressure of 6 atm (Group 1- POT-LP); and rated burst pressure (RBP) of 14 atm (Group
2- POT-RBP); Final Kissing Balloon Dilation (FKBD) methods using relatively under-
sized (‘US’) 3.5mm and 4.0mm balloons at RBP (Group 3 FKBD-US); FKBD using
adequately sized 4.0mm and 5.0mm balloons at low pressure (Group 4- FKBD-LP) and
ﬁnally at RBP (Group 5- FKBD- RBP).
RESULTS The platinum chromium stents 4.0mm stent reached an outer diameter of
only 5.1mm by using a 6.0 mm balloon at 6 atm. Further postdilatation with higher
pressures (14 atm) resulted in a stent outer diameter of 6.0mm, demonstrating a
safety margin above the designated expansion limit. Simultaneous kissing with un-
dersized balloon diameters resulted in a high ellipticity index and importantly mal-
apposition. Using correctly sized balloons, stent area improved but ellipticity
remained and malapposition was less but still higher compared to POT-LP and
POT-RBP.
CONCLUSIONS Our study shows that the thin strut platinum chromium 4.0mm stents
can be safely expanded with the use of POT beyond the overexpansion limit of
5.75mm with optimal stent apposition and performance. Proximal optimisation using
adequately sized balloons and high pressure is advised to achieve optimal outcome in
left main stenting.CRT-154
Intravascular Ultrasound Guided Left Main Interventions: Meta-analysis
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BACKGROUND Interventions of the left main coronary artery are complex and require
high degree of technical skills. Intravascular ultrasound (IVUS) can aid interventions
of the left main coronary artery. We performed this meta-analysis to assess the efﬁ-
cacy of use of IVUS compared to angiographic-guided PCI.
METHODS Electronic search of PubMed, EBSCO and Google Scholar databases was
done to identify studies of IVUS guided left main interventions. Pooled meta-analysis
of major adverse cardiac events (MACE), cardiac death, myocardial infarction (MI),
target vessel revascularization (TVR), target lesion revascularization (TLR) and stent
thrombosis was performed using Comprehensive Meta-analysis 2 software. Mantel-
Haenszel random effects model was used to compute the odds ratio (OR) for the
above outcomes with and without the use of IVUS.
RESULTS A total of 4 studies with 2607 patients were identiﬁed that compared left
main interventions done using with and without IVUS guidance. Interventions were
done using IVUS in 1576 and angiographic-guided interventions were performed in
1031 patients. The risk of MACE with the use of IVUS guided intervention was 0.64
(95% CI: 0.49 - 0.83). The use of IVUS decreased cardiovascular death (OR 0.37; 95%
CI: 0.23 -0.6) and MI (OR 0.69; 95% CI: 0.51 - 0.92). IVUS use in left main intervention
had a trend towards lower TVR (OR 0.66; 95% CI: 0.27 - 2.49), TLR (OR 0.74; 95% CI
0.5 - 1.09) and stent thrombosis (OR 0.26; 0.07 - 1.04).
CONCLUSION The use of IVUS for left main interventions is associated with 36%
lower risk of MACE, 31% lower risk of repeat MI and 63% lower risk of cardiovascular
death. The above ﬁndings suggest major outcomes beneﬁt with the use of IVUS for
left main interventions.OTHER
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OBJECTIVE he aim of this registry is to evaluate the clinical performance of a new
generation Sirolimus eluting stent system (Orsiro) in a large patient population in
standard clinical care.
The Orsiro is a unique hybrid solution that combines passive and active compo-
nents. PROBIO passive coating encapsulates the stent and minimizes interaction
between the metal stent and surrounding tissue. BIOlute active coating contains a
highly biocompatible and biodegradable polymer.
METHODS Between August 2011 and March 2012, 1,356 subjects were enrolled
consecutively in this international, multicentric BIOFLOW-III all-comers registry us-
ing the Orsiro Sirolimus eluting stent.
Primary endpoint is Target Lesion Failure (TLF) at twelve months follow-up. Pre-
speciﬁed subgroups were diabetes, small vessels, chronic total occlusion and
